{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:00:10Z","timestamp":1790856010359,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31771181"],"award-info":[{"award-number":["31771181"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Provincial Project of Natural Science Research for Colleges and Universities of Anhui Province of China","award":["KJ2019ZD34"],"award-info":[{"award-number":["KJ2019ZD34"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Recent findings elucidated hepatic PPAR\u03b3 functions as a steatogenic-inducer gene that activates <jats:italic>de novo<\/jats:italic> lipogenesis, and is involved in regulation of glucose homeostasis, lipid accumulation, and inflammation response. This study delved into a comprehensive analysis of how PPAR\u03b3 signaling affects the exercise-induced improvement of insulin resistance (IR) and non-alcoholic fatty liver disease (NAFLD), along with its underlying mechanism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Chronic and acute swimming exercise intervention were conducted in each group mice. IR status was assessed by GTT and ITT assays. Serum inflammatory cytokines were detected by Elisa assays. PPAR\u03b3 and its target genes expression were detected by qPCR assay. Relative protein levels were quantified via Western blotting. ChIP-qPCR assays were used to detect the enrichment of PPAR\u03b3 on its target genes promoter.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Through an exploration of a high-fat diet (HFD)-induced IR and NAFLD model, both chronic and acute swimming exercise training led to significant reductions in body weight and visceral fat mass, as well as hepatic lipid accumulation. The exercise interventions also demonstrated a significant amelioration in IR and the inflammatory response. Meanwhile, swimming exercise significantly inhibited PPAR\u03b3 and its target genes expression induced by HFD, containing CD36, SCD1 and PLIN2. Furthermore, swimming exercise presented significant modulation on regulatory factors of PPAR\u03b3 expression and transcriptional activity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The findings suggest that swimming exercise can improve lipid metabolism in IR and NAFLD, possibly through PPAR\u03b3 signaling in the liver of mice.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10020-023-00740-4","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T12:01:45Z","timestamp":1698753705000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Swimming exercise ameliorates insulin resistance and nonalcoholic fatty liver by negatively regulating PPAR\u03b3 transcriptional network in mice fed high fat diet"],"prefix":"10.1186","volume":"29","author":[{"given":"Yong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuofeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianmiao","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4295-4537","authenticated-orcid":false,"given":"Qingyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"issue":"5","key":"740_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.dld.2017.01.147","volume":"49","author":"AISF","year":"2017","unstructured":"AISF. Position paper on nonalcoholic fatty Liver Disease (NAFLD): updates and future directions. Dig Liver Dis. 2017;49(5):471\u201383.","journal-title":"Dig Liver Dis"},{"key":"740_CR49","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.metabol.2018.08.006","volume":"89","author":"F Bian","year":"2018","unstructured":"Bian F, et al. TET2 facilitates PPAR\u03b3 agonist-mediated gene regulation and insulin sensitization in adipocytes. Metabolism. 2018;89:39\u201347.","journal-title":"Metabolism"},{"issue":"2","key":"740_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/MED.0b013e3283444b09","volume":"18","author":"G Boden","year":"2011","unstructured":"Boden G. Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes. 2011;18(2):139\u201343.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"3","key":"740_CR38","doi-asserted-by":"publisher","first-page":"E586","DOI":"10.1152\/ajpendo.00309.2007","volume":"295","author":"RL Bradley","year":"2008","unstructured":"Bradley RL, et al. Voluntary exercise improves insulin sensitivity and adipose tissue inflammation in diet-induced obese mice. Am J Physiol Endocrinol Metab. 2008;295(3):E586\u201394.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"740_CR1","doi-asserted-by":"crossref","unstructured":"Choi DH, Jung CH. Effect of Dapagliflozin on Alanine aminotransferase improvement in type 2 Diabetes Mellitus with non-alcoholic fatty Liver Disease. 2018;33(3):387\u201394.","DOI":"10.3803\/EnM.2018.33.3.387"},{"key":"740_CR42","doi-asserted-by":"crossref","unstructured":"Dong B et al. Vitamin D receptor activation in Liver macrophages ameliorates hepatic inflammation, Steatosis, and Insulin Resistance in mice. 2020;71(5):1559\u201374.","DOI":"10.1002\/hep.30937"},{"key":"740_CR39","doi-asserted-by":"crossref","unstructured":"Effting PS, Thirupathi A. Resistance Exercise Training improves metabolic and Inflammatory Control in Adipose and Muscle Tissues in Mice Fed a High-Fat Diet. 2022;14(11).","DOI":"10.3390\/nu14112179"},{"issue":"8","key":"740_CR36","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.2337\/db06-1698","volume":"56","author":"C Fr\u00f8sig","year":"2007","unstructured":"Fr\u00f8sig C, et al. Effects of endurance exercise training on insulin signaling in human skeletal muscle: interactions at the level of phosphatidylinositol 3-kinase, akt, and AS160. Diabetes. 2007;56(8):2093\u2013102.","journal-title":"Diabetes"},{"issue":"1","key":"740_CR40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1017\/S095442241400002X","volume":"27","author":"G Fr\u00fchbeck","year":"2014","unstructured":"Fr\u00fchbeck G, et al. Regulation of adipocyte lipolysis. Nutr Res Rev. 2014;27(1):63\u201393.","journal-title":"Nutr Res Rev"},{"issue":"39","key":"740_CR4","doi-asserted-by":"publisher","first-page":"29965","DOI":"10.1074\/jbc.M110.128694","volume":"285","author":"D Gao","year":"2010","unstructured":"Gao D, et al. The effects of palmitate on hepatic insulin resistance are mediated by NADPH oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways. J Biol Chem. 2010;285(39):29965\u201373.","journal-title":"J Biol Chem"},{"issue":"3","key":"740_CR17","doi-asserted-by":"publisher","first-page":"900","DOI":"10.2337\/db13-0436","volume":"63","author":"T Garin-Shkolnik","year":"2014","unstructured":"Garin-Shkolnik T, et al. FABP4 attenuates PPAR\u03b3 and adipogenesis and is inversely correlated with PPAR\u03b3 in adipose tissues. Diabetes. 2014;63(3):900\u201311.","journal-title":"Diabetes"},{"issue":"10","key":"740_CR37","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1016\/j.celrep.2019.02.014","volume":"26","author":"L Geng","year":"2019","unstructured":"Geng L, et al. Exercise alleviates obesity-Induced metabolic dysfunction via enhancing FGF21 sensitivity in adipose tissues. Cell Rep. 2019;26(10):2738\u20132752e4.","journal-title":"Cell Rep"},{"issue":"5","key":"740_CR35","doi-asserted-by":"publisher","first-page":"e63517","DOI":"10.1371\/journal.pone.0063517","volume":"8","author":"KH Kim","year":"2013","unstructured":"Kim KH, et al. Acute exercise induces FGF21 expression in mice and in healthy humans. PLoS ONE. 2013;8(5):e63517.","journal-title":"PLoS ONE"},{"issue":"1","key":"740_CR20","first-page":"162","volume":"8","author":"K Kim","year":"2017","unstructured":"Kim K, et al. ROR\u03b1 Controls Hepatic Lipid Homeostasis via Negative Regulation of PPAR\u03b3 Transcriptional Network. 2017;8(1):162.","journal-title":"ROR\u03b1 Controls Hepatic Lipid Homeostasis via Negative Regulation of PPAR\u03b3 Transcriptional Network"},{"key":"740_CR12","doi-asserted-by":"crossref","unstructured":"Lavoie JM, Pighon A. NAFLD, Estrogens, and Physical Exercise: The Animal Model. J Nutr Metab, 2012;2012:914938.","DOI":"10.1155\/2012\/914938"},{"issue":"3","key":"740_CR43","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3109\/10409238.2011.562481","volume":"46","author":"KF Leavens","year":"2011","unstructured":"Leavens KF, Birnbaum MJ. Insulin signaling to hepatic lipid metabolism in health and Disease. Crit Rev Biochem Mol Biol. 2011;46(3):200\u201315.","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"1","key":"740_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/jgh.12428","volume":"29","author":"Z Li","year":"2014","unstructured":"Li Z, et al. Prevalence of nonalcoholic fatty Liver Disease in mainland of China: a meta-analysis of published studies. J Gastroenterol Hepatol. 2014;29(1):42\u201351.","journal-title":"J Gastroenterol Hepatol"},{"issue":"47","key":"740_CR52","doi-asserted-by":"publisher","first-page":"18832","DOI":"10.1073\/pnas.1309469110","volume":"110","author":"J Liu","year":"2013","unstructured":"Liu J, et al. Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase. Proc Natl Acad Sci U S A. 2013;110(47):18832\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"740_CR5","doi-asserted-by":"publisher","first-page":"5684","DOI":"10.1038\/ncomms6684","volume":"5","author":"W Liu","year":"2014","unstructured":"Liu W, et al. Hepatic miR-378 targets p110alpha and controls glucose and lipid homeostasis by modulating hepatic insulin signalling. Nat Commun. 2014a;5:5684.","journal-title":"Nat Commun"},{"key":"740_CR8","doi-asserted-by":"publisher","first-page":"5684","DOI":"10.1038\/ncomms6684","volume":"5","author":"W Liu","year":"2014","unstructured":"Liu W, et al. Hepatic miR-378 targets p110\u03b1 and controls glucose and lipid homeostasis by modulating hepatic insulin signalling. Nat Commun. 2014b;5:5684.","journal-title":"Nat Commun"},{"issue":"3","key":"740_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.dld.2014.09.020","volume":"47","author":"A Lonardo","year":"2015","unstructured":"Lonardo A, et al. Nonalcoholic fatty Liver Disease: a precursor of the metabolic syndrome. Dig Liver Dis. 2015;47(3):181\u201390.","journal-title":"Dig Liver Dis"},{"issue":"36","key":"740_CR27","doi-asserted-by":"publisher","first-page":"6571","DOI":"10.3748\/wjg.v23.i36.6571","volume":"23","author":"A Lonardo","year":"2017","unstructured":"Lonardo A, et al. Nonalcoholic fatty Liver Disease: evolving paradigms. World J Gastroenterol. 2017;23(36):6571\u201392.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"740_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/MEG.0000000000000254","volume":"27","author":"J Luo","year":"2015","unstructured":"Luo J, et al. Nonalcoholic fatty Liver Disease as a potential risk factor of Cardiovascular Disease. Eur J Gastroenterol Hepatol. 2015;27(3):193\u20139.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"740_CR53","doi-asserted-by":"publisher","first-page":"44612","DOI":"10.1038\/srep44612","volume":"7","author":"W Luo","year":"2017","unstructured":"Luo W, et al. Effect of modulation of PPAR-\u03b3 activity on Kupffer cells M1\/M2 polarization in the development of non-alcoholic fatty Liver Disease. Sci Rep. 2017;7:44612.","journal-title":"Sci Rep"},{"issue":"5","key":"740_CR32","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1002\/hep.30062","volume":"68","author":"P Luo","year":"2018","unstructured":"Luo P, et al. Ubiquitin-Specific Peptidase 10 (USP10) inhibits hepatic steatosis, insulin resistance, and inflammation through Sirt6. Hepatology. 2018;68(5):1786\u2013803.","journal-title":"Hepatology"},{"key":"740_CR18","doi-asserted-by":"crossref","unstructured":"Luo J et al. Nrf2 Deficiency Exacerbated CLP-Induced Pulmonary Injury and inflammation through Autophagy- and NF-\u03baB\/PPAR\u03b3-Mediated macrophage polarization. Cells, 2022;11(23).","DOI":"10.3390\/cells11233927"},{"issue":"4","key":"740_CR22","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.cmet.2008.03.003","volume":"7","author":"K Matsusue","year":"2008","unstructured":"Matsusue K, et al. Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27. Cell Metab. 2008;7(4):302\u201311.","journal-title":"Cell Metab"},{"issue":"9","key":"740_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrendo.2017.56","volume":"13","author":"RCR Meex","year":"2017","unstructured":"Meex RCR, Watt MJ. Hepatokines: linking nonalcoholic fatty Liver Disease and insulin resistance. Nat Rev Endocrinol. 2017;13(9):509\u201320.","journal-title":"Nat Rev Endocrinol"},{"issue":"51","key":"740_CR45","doi-asserted-by":"publisher","first-page":"51664","DOI":"10.1074\/jbc.M309377200","volume":"278","author":"EP Newberry","year":"2003","unstructured":"Newberry EP, et al. Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid-binding protein gene. J Biol Chem. 2003;278(51):51664\u201372.","journal-title":"J Biol Chem"},{"key":"740_CR19","doi-asserted-by":"crossref","unstructured":"Ning Z, Guo X, Liu X. USP22 regulates lipidome accumulation by stabilizing PPAR\u03b3 in hepatocellular carcinoma. 2022;13(1):2187.","DOI":"10.1038\/s41467-022-29846-9"},{"issue":"6","key":"740_CR3","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/j.1440-1746.2004.03362.x","volume":"19","author":"SH Park","year":"2004","unstructured":"Park SH, et al. Insulin resistance and C-reactive protein as Independent risk factors for non-alcoholic fatty Liver Disease in non-obese Asian men. J Gastroenterol Hepatol. 2004;19(6):694\u20138.","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"740_CR24","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1172\/JCI90327","volume":"127","author":"C Patitucci","year":"2017","unstructured":"Patitucci C, et al. Hepatocyte nuclear factor 1\u03b1 suppresses steatosis-associated Liver cancer by inhibiting PPAR\u03b3 transcription. J Clin Invest. 2017;127(5):1873\u201388.","journal-title":"J Clin Invest"},{"issue":"1","key":"740_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1210\/er.2002-0012","volume":"24","author":"P Puigserver","year":"2003","unstructured":"Puigserver P, Spiegelman BM. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev. 2003;24(1):78\u201390.","journal-title":"Endocr Rev"},{"issue":"1","key":"740_CR47","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1053\/j.gastro.2008.03.078","volume":"135","author":"V Ratziu","year":"2008","unstructured":"Ratziu V, et al. Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled fatty liver improvement with Rosiglitazone Therapy (FLIRT) Trial. Gastroenterology. 2008;135(1):100\u201310.","journal-title":"Gastroenterology"},{"issue":"2","key":"740_CR48","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/hep.23270","volume":"51","author":"V Ratziu","year":"2010","unstructured":"Ratziu V, et al. Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial. Hepatology. 2010;51(2):445\u201353.","journal-title":"Hepatology"},{"issue":"4","key":"740_CR29","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","volume":"67","author":"M Romero-G\u00f3mez","year":"2017","unstructured":"Romero-G\u00f3mez M, Zelber-Sagi S, Trenell M. Treatment of NAFLD with diet, physical activity and exercise. J Hepatol. 2017;67(4):829\u201346.","journal-title":"J Hepatol"},{"issue":"2","key":"740_CR50","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.2042-7158.2011.01366.x","volume":"64","author":"N Saraf","year":"2012","unstructured":"Saraf N, et al. Role of PPARg2 transcription factor in thiazolidinedione-induced insulin sensitization. J Pharm Pharmacol. 2012;64(2):161\u201371.","journal-title":"J Pharm Pharmacol"},{"key":"740_CR41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12944-015-0123-1","volume":"14","author":"B Sears","year":"2015","unstructured":"Sears B, Perry M. The role of fatty acids in insulin resistance. Lipids Health Dis. 2015;14:121.","journal-title":"Lipids Health Dis"},{"issue":"5","key":"740_CR46","doi-asserted-by":"publisher","first-page":"E969","DOI":"10.1152\/ajpendo.00497.2007","volume":"294","author":"M Stefanovic-Racic","year":"2008","unstructured":"Stefanovic-Racic M, et al. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels. Am J Physiol Endocrinol Metab. 2008;294(5):E969\u201377.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"740_CR13","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3892\/ijmm.2015.2076","volume":"35","author":"C Sun","year":"2015","unstructured":"Sun C, et al. miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty Liver Disease by targeting HMGCR. Int J Mol Med. 2015;35(3):847\u201353.","journal-title":"Int J Mol Med"},{"issue":"3","key":"740_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","volume":"65","author":"G Targher","year":"2016","unstructured":"Targher G, et al. Non-alcoholic fatty Liver Disease and risk of incident Cardiovascular Disease: a meta-analysis. J Hepatol. 2016;65(3):589\u2013600.","journal-title":"J Hepatol"},{"issue":"10","key":"740_CR34","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.tem.2008.08.005","volume":"19","author":"H Tilg","year":"2008","unstructured":"Tilg H, Moschen AR. Insulin resistance, inflammation, and non-alcoholic fatty Liver Disease. Trends Endocrinol Metab. 2008;19(10):371\u20139.","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"740_CR21","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1002\/hep.30559","volume":"69","author":"J Tong","year":"2019","unstructured":"Tong J, et al. Hepatic Interferon Regulatory Factor 6 alleviates liver steatosis and metabolic disorder by transcriptionally suppressing peroxisome proliferator-activated receptor \u03b3 in mice. Hepatology. 2019;69(6):2471\u201388.","journal-title":"Hepatology"},{"issue":"1","key":"740_CR10","doi-asserted-by":"publisher","first-page":"e0147985","DOI":"10.1371\/journal.pone.0147985","volume":"11","author":"J Wei","year":"2016","unstructured":"Wei J, et al. Association between Dietary Vitamin C Intake and non-alcoholic fatty Liver Disease: a cross-sectional study among middle-aged and older adults. PLoS ONE. 2016;11(1):e0147985.","journal-title":"PLoS ONE"},{"key":"740_CR55","doi-asserted-by":"crossref","unstructured":"Wilson RA et al. Intermittent fasting with or without Exercise prevents Weight Gain and improves lipids in Diet-Induced obese mice. Nutrients, 2018;10(3).","DOI":"10.3390\/nu10030346"},{"issue":"12","key":"740_CR16","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.7150\/ijbs.62556","volume":"17","author":"Y Xu","year":"2021","unstructured":"Xu Y, et al. Berberine modulates deacetylation of PPAR\u03b3 to promote adipose tissue remodeling and thermogenesis via AMPK\/SIRT1 pathway. Int J Biol Sci. 2021;17(12):3173\u201387.","journal-title":"Int J Biol Sci"},{"key":"740_CR15","doi-asserted-by":"publisher","first-page":"951689","DOI":"10.3389\/fendo.2022.951689","volume":"13","author":"Y Xue","year":"2022","unstructured":"Xue Y, et al. Potential screening indicators for early diagnosis of NAFLD\/MAFLD and liver fibrosis: triglyceride glucose index-related parameters. Front Endocrinol (Lausanne). 2022;13:951689.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"740_CR44","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/hep.28971","volume":"65","author":"FJ Yan","year":"2017","unstructured":"Yan FJ, et al. The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis. Hepatology. 2017;65(5):1492\u2013511.","journal-title":"Hepatology"},{"issue":"3","key":"740_CR54","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1053\/j.gastro.2020.11.051","volume":"160","author":"ZM Younossi","year":"2021","unstructured":"Younossi ZM, Corey KE, Lim JK. AGA clinical practice update on Lifestyle Modification using Diet and Exercise to achieve weight loss in the management of nonalcoholic fatty Liver Disease: Expert Review. Gastroenterology. 2021;160(3):912\u20138.","journal-title":"Gastroenterology"},{"issue":"5","key":"740_CR28","doi-asserted-by":"publisher","first-page":"e5129","DOI":"10.1590\/1414-431x20165129","volume":"49","author":"J Yu","year":"2016","unstructured":"Yu J, et al. Exercise improved lipid metabolism and insulin sensitivity in rats fed a high-fat diet by regulating glucose transporter 4 (GLUT4) and musclin expression. Braz J Med Biol Res. 2016;49(5):e5129.","journal-title":"Braz J Med Biol Res"},{"key":"740_CR30","doi-asserted-by":"crossref","unstructured":"Zhang Y et al. Exercise ameliorates insulin resistance via regulating TGF\u03b2-activated kinase 1 (TAK1)-mediated insulin signaling in liver of high-fat diet-induced obese rats. 2019;234(5):7467\u201374.","DOI":"10.1002\/jcp.27508"},{"key":"740_CR31","doi-asserted-by":"crossref","unstructured":"Zhang Y et al. Exercise ameliorates insulin resistance and improves ASK1-mediated insulin signalling in obese rats. 2021;25(23):10930\u20138.","DOI":"10.1111\/jcmm.16994"},{"issue":"3","key":"740_CR33","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/hep.29889","volume":"68","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, et al. Ubiquitin-specific protease 4 is an endogenous negative Regulator of metabolic dysfunctions in nonalcoholic fatty Liver Disease in mice. Hepatology. 2018;68(3):897\u2013917.","journal-title":"Hepatology"},{"issue":"1","key":"740_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/hep.25611","volume":"56","author":"L Zhou","year":"2012","unstructured":"Zhou L, et al. Cidea promotes hepatic steatosis by sensing dietary fatty acids. Hepatology. 2012;56(1):95\u2013107.","journal-title":"Hepatology"},{"issue":"8","key":"740_CR51","doi-asserted-by":"publisher","first-page":"7350","DOI":"10.18632\/aging.103082","volume":"12","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, et al. Inhibition of stearoyl-coenzyme A desaturase 1 ameliorates hepatic steatosis by inducing AMPK-mediated lipophagy. Aging. 2020;12(8):7350\u201362.","journal-title":"Aging"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-023-00740-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-023-00740-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-023-00740-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T12:03:09Z","timestamp":1698753789000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-023-00740-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["740"],"URL":"https:\/\/doi.org\/10.1186\/s10020-023-00740-4","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]},"assertion":[{"value":"14 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki was approved by the Institute Research Ethics Committee at Anhui Normal University. The animal experiments were carried out in compliance with the ARRIVE guidelines. All methods in this study were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that there are no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"150"}}